Imricor Medical Systems (ASX:IMR) Change In Receivables : A$0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Imricor Medical Systems Change In Receivables?

Imricor Medical Systems's change in receivables for the quarter that ended in Dec. 2024 was A$0.00 Mil. It means Imricor Medical Systems's Accounts Receivable stayed the same from Jun. 2024 to Dec. 2024 .

Imricor Medical Systems's change in receivables for the fiscal year that ended in Dec. 2024 was A$0.00 Mil. It means Imricor Medical Systems's Accounts Receivable stayed the same from Dec. 2023 to Dec. 2024 .

Imricor Medical Systems's Accounts Receivable for the quarter that ended in Dec. 2024 was A$0.55 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Imricor Medical Systems's Days Sales Outstanding for the six months ended in Dec. 2024 was 103.82.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Imricor Medical Systems's liquidation value for the six months ended in Dec. 2024 was A$-19.40 Mil.

Imricor Medical Systems Change In Receivables Historical Data

The historical data trend for Imricor Medical Systems's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imricor Medical Systems Change In Receivables Chart

Imricor Medical Systems Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

Imricor Medical Systems Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Receivables	Get a 7-Day Free Trial							-	-	-	-	-

Imricor Medical Systems Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

Imricor Medical Systems (ASX:IMR) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Imricor Medical Systems's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.545	/	0.958	*	91
=	103.82

2. In Ben Graham's calculation of liquidation value, Imricor Medical Systems's accounts receivable are only considered to be worth 75% of book value:

Imricor Medical Systems's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	24.803	-	45.793	+	0.75 * 0.545	+	0.5 * 2.372
=	-19.40

Imricor Medical Systems Change In Receivables Related Terms

Thank you for viewing the detailed overview of Imricor Medical Systems's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Imricor Medical Systems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Imricor Medical Systems Inc (ASX:IMR) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

400 Gateway Boulevard, Burnsville, MN, USA, 55337

Website

https://www.imricor.com

Imricor Medical Systems Inc is a medical device company engaged in addressing issues with traditional x-ray-guided ablation procedures through the development of MRI-guided technology. Its principal business activities are to design, manufacture and sell MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. The products of the company include Advantage-MR EP Recorder/Stimulator, Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode.

Imricor Medical Systems Headlines

No Headlines